Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00762242 · ClinicalTrials.gov registry record
Metabolomic Profiling of Novel Mediators of Vascular Function
A clinical trial, sponsored by Brigham and Women's Hospital.
- Terminated
- Registry status
- 48
- Enrollment target
NCT00762242: Clinical Trial study, sponsored by Brigham and Women's Hospital.
NCT00762242 is a clinical trial that was terminated before completion, run by Brigham and Women's Hospital. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00762242 was terminated before completion, sponsored by Brigham and Women's Hospital.
- TERMINATED
- Registry status
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to identify and characterize specific chemicals and metabolic pathways that change with forearm ischemia. These changes will be compared with forearm blood flow and flow-mediated vasodilation of the brachial artery.
Interventions
- PROCEDURE blood sampling and brachial artery ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2007-05 |
| Est. Completion | 2018-02 |
Why NCT00762242 stopped before completion
NCT00762242 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which blood sampling and brachial artery ultrasound is the first listed.
NCT00762242 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00762242 about?
NCT00762242 is a clinical study titled "Metabolomic Profiling of Novel Mediators of Vascular Function". The purpose of this study is to identify and characterize specific chemicals and metabolic pathways that change with forearm ischemia. These changes will be compared with forearm blood flow and flow-mediated vasodilation of the brachial artery.
What is the current status of trial NCT00762242?
This trial is currently terminated. The enrollment target is 48 participants. The study started on 2007-05. Estimated completion is 2018-02.
What interventions are being tested in trial NCT00762242?
The interventions under investigation include: blood sampling and brachial artery ultrasound (PROCEDURE).
Who is sponsoring clinical trial NCT00762242?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia